Overview
Lobbying Costs
200,000€ - 299,999€
Financial year: Jan 2021 - Dec 2021
Lobbyists (Full time equivalent)
0.2 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
4
Lobbying Costs over the years
-
Info
Moderna Inc.
EU Transparency Register
011080341579-06 First registered on 24 Feb 2021
Goals / Remit
Moderna’s mRNA technology quickly enabled us to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19. In this context, Moderna made APA and contracts with the European Commission. Building on its mRNA platform, Moderna is also developing mRNA vaccines and therapies against other infectious diseases, and non-infectious diseases in oncology, CVD, rare diseases.
Main EU files targeted
Moderna has monitored and is interested in the following topics and policies :
Covid 19 vaccines policies & procurement mechanisms
EU Vaccine policy
HERA & biopreparedness
Pharma strategy
Revision of Pharma regulationAddress
Head Office
200 Technology Square
Cambridge 02139
UNITED STATESEU Office
200 Technology Square
Cambridge 02139
UNITED STATESWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 10% 2 Lobbyists (Full time equivalent)
0.2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 13 May 2022
Name Start date End Date Maren DR. VON FRITSCHEN 18 Jan 2024 17 Jan 2025 Mr Alexander DR. MEIER 18 Jan 2024 17 Jan 2025 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Vaccines Europe : https://www.vaccineseurope.eu
Member organisations
N/A
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2021 - Dec 2021
Lobbying costs for closed financial year
200,000€ - 299,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount fti consulting 10,000€ - 24,999€ fipra international 100,000€ - 199,999€ Intermediaries for current year
Name fipra international fti consulting Closed year Costs
200,000€ - 299,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Outreach emails to communicate Moderna announcements
Other activities
None declared
- Meetings
Meetings
4 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 03 Nov 2022 Location Bruxelles Subject Videoconference with Moderna CEO on future of mRNA platform; ongoing cooperation on the management of the pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Daphne von Buxhoeveden (Cabinet member)
-
Date 26 Nov 2021 Location Videoconference Subject Meeting with CEO of Moderna Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
-
Date 10 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists
- Meetings